Blood clot risks are high following SARS-CoV-2 infection, not vaccination
Wednesday, September 15, 2021 01:27 PM
Researchers from the University of Oxford have today announced the results of a study into thrombocytopenia (a condition with low platelet counts) and thromboembolic events (blood clots) following vaccination for Covid-19, some of the same events which have led to restricted use of the Oxford-AstraZeneca vaccine in a number of countries. Read more.